Beyond Novo: Fund manager likes this under-the-radar pharma stock with a weight loss drug in the works

By CNBC (World News) | Created at 2024-10-03 23:25:26 | Updated at 2024-10-04 01:23:33 2 hours ago

Published Thu, Oct 3 20247:20 PM EDT